Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Special shake may help blood cancer patients recover from stem cell transplant

NCT ID NCT05460013

First seen May 12, 2026 · Last updated Jun 23, 2026 · Updated 10 times

Summary

This study tested whether a special oral nutritional supplement (Ensure Complete) could help patients with blood cancer maintain weight and gut function after a stem cell transplant. 100 participants were randomly assigned to receive either the supplement or a standard hospital shake for 7 days before transplant until discharge. The main goal was to see if the supplement helped prevent weight loss at 28 days after transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMATOLOGICAL MALIGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, 200124, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Oral nutritional supplement (Ensure Complete with fiber)

What this could lead to

If it works, this could show that a simple nutritional drink helps patients maintain weight and gut function during stem cell transplant recovery.

What could go wrong

This is a small, completed study with only 100 participants from one hospital. The supplement may not significantly improve outcomes over standard care.

Conditions

The condition(s) this trial relates to.

Body Weight hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.